Stefan Bijmolt

Zoekresultaten

• 2019

  Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer

  Wortman, B., Astreinidou, E., Laman, M., Lutgens, L., Van der Steen-Banasik, E., Slot, A., Westerveld, H., De Winter, K., Van den Berg, H., Bloemers, M., Stam, T., Mens, J., Zwanenburg, L., Bijmolt, S., Juergenliemk-Schulz, I., Snyers, A., Creutzberg, C. & Nout, R., apr.-2019, In: Radiotherapy and Oncology. 133, blz. S198-S199 2 blz.

  Onderzoeksoutput › Academic

  Open Access

  Bestand
  66 Downloads (Pure)

• Feasibility planning study for hypofractionated salvage prostate bed radiotherapy

  Koopman, L., Van der Neut, S., Roos, C., Hammer, C., Vanhauten, H., Bijmolt, S., Van den Bergh, A., Lagendijk, J., Both, S., Brouwer, C. & Al-Uwini, S., apr.-2019, In: Radiotherapy and Oncology. 133, blz. S1206-S1206 1 blz.

  Onderzoeksoutput › Academic

  Open Access

  Bestand
  75 Downloads (Pure)

• Feasibility study of extreme hypofractionated proton treatment planning for prostate cancer

  Klinker, P., Brouwer, C., Roos, C., Hammer, C., Vanhauten, H., Bijmolt, S., Langendijk, J., Both, S., Van den Bergh, A. & Al-Uwini, S., apr.-2019, In: Radiotherapy and Oncology. 133, blz. S994-S995 2 blz.

  Onderzoeksoutput › Academic

  Open Access